Status:
RECRUITING
Assessment of Neurofilaments Levels in Premature Newborns: Study of Their Early Development
Lead Sponsor:
Centre Hospitalier Universitaire de Liege
Collaborating Sponsors:
Centre Hospitalier Régional de la Citadelle
Conditions:
Healthy Participants
Eligibility:
All Genders
Up to 3 years
Brief Summary
This is a prospective observational study aiming to establish reference values of neurofilaments in late preterm newborns (34-37 weeks of gestation) and to evaluate their early postnatal evolution. N...
Detailed Description
Recent therapeutic advances in spinal muscular atrophy (SMA) have highlighted the importance of very early treatment, ideally before the onset of symptoms. Neurofilaments, structural proteins of neuro...
Eligibility Criteria
Inclusion
- Gestational age between 34 and 37 weeks of amenorrhea.
- Blood test scheduled for clinical reasons.
- Signed parental consent.
Exclusion
- Known neurological disorders.
- Severe congenital malformations.
- Medical contraindication to blood sampling.
Key Trial Info
Start Date :
December 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT07159555
Start Date
December 1 2025
End Date
December 31 2026
Last Update
December 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Citadelle
Liège, Belgium, 4000